{"provider_url":"https://hatena.blog","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fmarfan-info.hatenablog.com%2Fentry%2F2025%2F03%2F31%2F214341\" title=\"\u8840\u5727\u6b63\u5e38\u304b\u3089\u4f4e\u3081\u306e\u60a3\u8005\u306b\u5bfe\u3059\u308bARB\u306e\u6295\u4e0e\u306b\u3064\u3044\u3066 - \u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","height":"190","width":"100%","provider_name":"Hatena Blog","author_name":"marfan-info","description":"Managing HTAD: Key Insights from the 2024 ESC Guidelines 1:07:34-1:10:43 Q: Is the use of ARBs recommended in Marfan patients whose blood pressure is normal to low and this person has a abdominal aneurysm which is followed annually and the surgery is not indicated yet, so would the ARBs lower their \u2026","version":"1.0","published":"2025-03-31 21:43:41","image_url":null,"url":"https://marfan-info.hatenablog.com/entry/2025/03/31/214341","type":"rich","author_url":"https://blog.hatena.ne.jp/marfan-info/","title":"\u8840\u5727\u6b63\u5e38\u304b\u3089\u4f4e\u3081\u306e\u60a3\u8005\u306b\u5bfe\u3059\u308bARB\u306e\u6295\u4e0e\u306b\u3064\u3044\u3066","blog_url":"https://marfan-info.hatenablog.com/","blog_title":"\u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates","categories":["\u30aa\u30f3\u30e9\u30a4\u30f3\u30bb\u30df\u30ca\u30fc","Q & A","\u5faa\u74b0\u5668","\u85ac"]}